ArticleBlood cancer journal2023
Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study.
Abstract readLetter
In one paragraph
Article in Blood cancer journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- CD84 Expression Across Disease Stages and Leukemic Subpopulations in Acute Myeloid Leukemia.Cancers · 2026Article
- Article
- An Update on Flow Cytometry Analysis of Hematological Malignancies: Focus on Standardization.Cancers · 2025Review
- Quantitative detection of macular microvascular abnormalities identified by optical coherence tomography angiography in different hematological diseases.Scientific reports · 2024Article
- Criteria for Diagnosis and Molecular Monitoring of NPM1-Mutated AML.Blood cancer discovery · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
39 authors.
Sergio Matarraz *Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. smats@usal.es.ORCID http://orcid.org/0000-0003-4634-8005
Pilar LeozBiomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.ORCID http://orcid.org/0000-0002-1139-5373
Ana Yeguas-BermejoBiomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.
Vincent van der VeldenDepartment of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-9457-3763
Anne E BrasDepartment of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Jose I Sánchez GallegoTranslational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.ORCID http://orcid.org/0000-0001-7906-9032
Quentin LecrevisseTranslational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.ORCID http://orcid.org/0000-0001-8715-5846
Rosa Ayala-BuenoTranslational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Cristina TeodosioTranslational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Ignacio CriadoTranslational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
María González-GonzálezTranslational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Juan Flores-MonteroBiomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.ORCID http://orcid.org/0000-0002-1119-4387
Alejandro AvendañoBiomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.
María B VidrialesBiomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.ORCID http://orcid.org/0000-0001-5049-3673
María C ChillónBiomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.
Teresa GonzálezBiomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.
Ramón García-SanzBiomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.ORCID http://orcid.org/0000-0003-4120-2787
María I Prieto CondeBiomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.
Neus VillamorHematology Service, Hospital Clinic, Barcelona, Spain.
Laura MagnanoHematology Service, Hospital Clinic, Barcelona, Spain.ORCID http://orcid.org/0000-0002-6928-8386
Enrique ColadoHematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Paula FernándezFACS/Stem Cell Laboratory, Kantonsspital Aarau, Aarau, Switzerland.ORCID http://orcid.org/0000-0003-3237-6283
Edwin SonneveldDutch Childhood Oncology Group, The Hague, The Netherlands.
Jan PhilippéDepartment of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Michaela ReiterováCLIP-Department of Pediatric Hematology and Oncology, Second Medical Faculty, Charles University and University Hospital Motol, Prague, Czech Republic.
Juan C Caballero BerrocalDepartment of Hematology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Francisco J Diaz-GálvezDepartment of Hematology, Hospital Universitario de Burgos, Burgos, Spain.
Fernando RamosDepartment of Hematology, Complejo Asistencial Universitario de León, León, Spain.
Julio Dávila VallsDepartment of Hematology, Complejo Asistencial de Ávila, Ávila, Spain.
Raquel Manjón SánchezDepartment of Hematology, Complejo Asistencial de Zamora, Zamora, Spain.
Jackeline Solano TovarDepartment of Hematology, Complejo Asistencial Universitario de Palencia, Palencia, Spain.
Xavier CalvoPathology Service, Hospital del Mar, Barcelona, Spain.
Luis García AlonsoHematology Service, University Hospital of Getafe, Madrid, Spain.
Leonor ArenillasPathology Service, Hospital del Mar, Barcelona, Spain.
Sara AlonsoHematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain.ORCID http://orcid.org/0000-0003-0560-6362
Ariana FonsecaHematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Covadonga Quirós CasoHematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Jacques J M van DongenTranslational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.ORCID http://orcid.org/0000-0002-3650-7087
Alberto Orfao *Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. orfao@usal.es.ORCID http://orcid.org/0000-0002-0007-7230
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Leukemia, Myeloid, AcuteNucleophosminBone MarrowHumansMutationNucleophosmin
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.